We found publicly deposited microarray data that shows that PBOV1 expression in pancreatic cancer xenografts negatively responds to the treatment with HhAntag, one of the emerging anti-cancer Hedgehog inhibitor drugs. The gene discussed is PBOV1; the disease is pancreatic neoplasm.